China has unveiled draft regulations on gene-editing and other new biomedical technologies it considers to be "high-risk."
Disclaimer: No Business Standard Journalist was involved in creation of this content
Explore Business Standard
Explore Business Standard
China has unveiled draft regulations on gene-editing and other new biomedical technologies it considers to be "high-risk."
Disclaimer: No Business Standard Journalist was involved in creation of this content
First Published: Feb 27 2019 | 9:50 AM IST